10:00 AM CST
Everything you should know about the relationship between IP rights and the market authorization for launching a drug in Mexico
DO NOT MISS THE OPPORTUNITY AND REGISTER NOW
Marketing Authorization (MA) process in Mexico involves the direct or indirect participation of IP authority.
While it is true that each stage of the Marketing Authorization process includes particular steps, most of them have well-stablished guidelines; however, the stages related to IP rights are still under refinement.
In order to understand the relationship between actual IP rights and the MA prosecution process, Clarke Modet & Co offers wide range solutions from the IP point of view.
WHO SHOULD ATTEND?
Directed to in-house patent and legal professionals of pharmaceutical companies and their subsidiaries, to understand the relationship between IP rights and the market authorization prosecution process for a drug in Mexico.
IP services during Marketing Authorization (MA) process in Mexico:
Background: Search of patent documents related to a drug, Linkage system
Processing: Filling response to office actions from COFEPRIS related to IP matters
Monitoring: Importations and exportations vigilance
ABOUT THE SPEAKER
Sharemy has two years within Technological Intelligence Unit of Clarke, Modet & Co. Mexico performing patentability, prior art and clearance searches as well as freedom to operate studies, technological-competitive intelligence studies and providing technical advice regarding industrial property matters in the chemistry field.
She has participated in several organometallic chemistry projects related to homogeneous catalysis and novel pincer compounds being part of international congresses. She also has experience in the research & development area of environmental analysis and as a HPLC analyst.
She is also part of our specialized team dedicated to Pharmacy, Biotechnology & Chemistry IP consultancy.